181 related articles for article (PubMed ID: 27854009)
1. Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
Gronda E; Vanoli E
Curr Heart Fail Rep; 2016 Dec; 13(6):273-280. PubMed ID: 27854009
[TBL] [Abstract][Full Text] [Related]
2. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
[TBL] [Abstract][Full Text] [Related]
3. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
4. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
[TBL] [Abstract][Full Text] [Related]
5. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
Eur J Heart Fail; 2024 Apr; 26(4):1051-1061. PubMed ID: 38606555
[TBL] [Abstract][Full Text] [Related]
6. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
7. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
[TBL] [Abstract][Full Text] [Related]
8. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
[TBL] [Abstract][Full Text] [Related]
9. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
[TBL] [Abstract][Full Text] [Related]
10. Comment on "Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction".
Oliveira M
Rev Port Cardiol; 2015 Dec; 34(12):795-7. PubMed ID: 27099884
[TBL] [Abstract][Full Text] [Related]
11. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
[TBL] [Abstract][Full Text] [Related]
12. Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.
Gronda E; Seravalle G; Trevano FQ; Costantino G; Casini A; Alsheraei A; Lovett EG; Vanoli E; Mancia G; Grassi G
J Hypertens; 2015 Aug; 33(8):1704-8. PubMed ID: 26132760
[TBL] [Abstract][Full Text] [Related]
13. Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure.
Lindenfeld J; Gupta R; Grazette L; Ruddy JM; Tsao L; Galle E; Rogers T; Sears S; Zannad F
JACC Heart Fail; 2021 Jun; 9(6):430-438. PubMed ID: 33992562
[TBL] [Abstract][Full Text] [Related]
14. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
Bisognano J; Schneider JE; Davies S; Ohsfeldt RL; Galle E; Stojanovic I; Deering TF; Lindenfeld J; Zile MR
BMC Cardiovasc Disord; 2021 Mar; 21(1):155. PubMed ID: 33771104
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
16. Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction.
Ruddy JM; Kroman A; Baicu CF; Zile MR
Heart Fail Clin; 2024 Jan; 20(1):39-50. PubMed ID: 37953020
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of baroreflex activation therapy for heart failure: A meta-analysis of randomized controlled trials.
Cai G; Guo K; Zhang D; Qin S
Medicine (Baltimore); 2020 Nov; 99(45):e22951. PubMed ID: 33157936
[TBL] [Abstract][Full Text] [Related]
18. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
19. Baroreflex activation therapy in advanced heart failure therapy: insights from a real-world scenario.
Guckel D; Eitz T; El Hamriti M; Braun M; Khalaph M; Imnadze G; Fink T; Sciacca V; Sohns C; Sommer P; Nölker G
ESC Heart Fail; 2023 Feb; 10(1):284-294. PubMed ID: 36208130
[TBL] [Abstract][Full Text] [Related]
20. Baroreflex Activation Therapy in Congestive Heart Failure: Novel Findings and Future Insights.
Grassi G; Brambilla G; Pizzalla DP; Seravalle G
Curr Hypertens Rep; 2016 Aug; 18(8):60. PubMed ID: 27334011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
